Dermatology Search
Dermatology Dermatology
alopecia
ALOPECIA

Alopecia is an involuntary loss of hair usually in the scalp that may occur anywhere over the body.
Scarring alopecia is severe inflammation of the hair follicle result in irreversible damage.
Non-scarring alopecias are reversible.
Alopecia may  be abrupt or gradual in onset.
Most common causes include androgenic alopecia (male & female pattern baldness) & alopecia areata.
History should be reviewed for medications, severe diet restriction, vitamin A supplementation, thyroid symptoms, concomitant illness & stress factor.

Drug Information

Indication: Rheumatic fever, RA, allergic diseases, nephritic syndrome, bronchial asthma & other corticosteroid-indica...

Indication: Replacement therapy for acute adrenocortical insufficiency eg, Addison's disease, bilateral adrenalectomy; rel...

Indication: RA, acute gouty arthritis, bronchial asthma, serum sickness, lupus, nodular arthritis, allergic dermatitis, pe...

Indication: Stimulates hair growth & stabilizes hair loss in patients w/ alopecia androgenetica.

Indication: Allergic, collagen, dermatological, GI, desquamative gingivitis, hematologic, tuberculous meningitis, ophth, r...

Indication: Bronchial asthma, allergic disease, RA, juvenile RA, rheumatoid myocarditis, rheumatic myelitis, psoriasis, os...

Indication: Men w/ pattern hair loss (androgenetic alopecia).

Shincort
triamcinolone acetonide

Indication: RA, synovitis, allergic rhinitis, asthma, allergic dermatitis, pemphigus, allergic & inflammatory ophth di...

Indication: Primary or secondary adrenocortical insufficiency; endocrine, rheumatic, collagen, dermatologic, ophth, resp, ...

1  /  3
1  /  3
Editor's Recommendations
Most Read Articles
Trifarotene cream effective for face, trunk acne
28 May 2019
Trifarotene is safe, well-tolerated and effective in treating both facial and truncal acne, according to two phase III trials.
Antinuclear antibody negativity ups risk of malignancy in adult-onset dermatomyositis
08 May 2019
Antinuclear antibody (ANA) negativity appears to increase the likelihood of developing malignancy in patients with adult-onset dermatomyositis (DM) within 3 years of diagnosis of their DM, according to a recent study.
Ablative fractional CO2 laser effective for burn scars
20 May 2019
Three treatments of ablative fractional CO2 laser (AFCO2L) yield improvements in burn scar pain, itch and dermal architecture 6 weeks after treatment, a recent study has found.
Inflammatory eruptions tied to immune checkpoint inhibitors
11 Apr 2019
Immune checkpoint inhibitor therapy may lead to various inflammatory reactions with differing degrees of severity, suggests a recent study. Most rashes respond to topical treatment, but immunotherapy is often interrupted by immunobullous and exfoliative presentations.